Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page:
About CDC.gov

These recommendations update information on the vaccine and antiviral agents available for controlling influenza during the 1995-96 influenza season (superseding MMWR 1994;43(No. RR-9) 1-13 and MMWR 1994;43(No. RR-15): 1-10). The principal changes in...

United States, Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.); National Center for Infectious Diseases (U.S.), Division of Viral and Rickettsial Diseases.; National Immunization Program (Centers for Disease Control and Prevention), Epidemiology and Surveillance Division.;

&quot;This report updates 1999 recommendations by the Advisory Committee on Immunization Practices (ACIP) on the use of influenza vaccine and antiviral agents (MMWR 1999;48[No. RR-4]: 1-29). These recommendations include five principal changes: a...

United States, Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.); National Center for Infectious Diseases (U.S.), Division of Viral and Rickettsial Diseases.;

&quot;This report updates 1998 recommendations by the Advisory Committee on Immunization Practices (ACIP) on the use of influenza vaccine and antiviral agents (MMWR 1998;47[No. RR-6]:1-26). The principal changes include a) information on the infl...

United States, Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.); National Center for Infectious Diseases (U.S.), Division of Viral and Rickettsial Diseases.;

"These recommendations update information on the vaccine and antiviral agents available for controlling influenza during the 1996-97 influenza season (superseding MMWR 1995;44(No. RR-3):1-22). The principal changes include information about a) t...

United States, Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.); National Center for Infectious Diseases (U.S.), Division of Viral and Rickettsial Diseases.; National Immunization Program (Centers for Disease Control and Prevention), Epidemiology and Surveillance Division.;

&quot;This report updates the 2000 recommendations by the Advisory Committee on Immunization Practices (ACIP) on the use of influenza vaccine and antiviral agents (MMWR 2000;49[No. RR-3]:1-38). The 2001 recommendations include new or updated info...

United States, Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.); National Center for Infectious Diseases (U.S.), Division of Viral and Rickettsial Diseases.;

&quot;These recommendations update information concerning the vaccine and antiviral agents available for controlling influenza during the 1997-98 influenza season (superseding MMWR 1996;45[No. RR-5]:1-24). The principal changes include informatio...

United States, Advisory Committee on Immunization Practices.; National Center for Infectious Diseases (U.S.), Division of Viral and Rickettsial Diseases.; National Immunization Program (Centers for Disease Control and Prevention), Epidemiology and Surveillance Division.;

This report summarizes recommendations by the Advisory Committee on Immunization Practices (ACIP) for using intranasally administered, trivalent, cold-adapted, live, attenuated influenza vaccine (LAIV), which was approved for use in the United States...

United States, Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.); National Center for Infectious Diseases (U.S.), Division of Viral and Rickettsial Diseases.;

National Center for Infectious Diseases (U.S.), Division of Viral and Rickettsial Diseases.; National Immunization Program (Centers for Disease Control and Prevention), Epidemiology and Surveillance Division.; United States, Advisory Committee on Immunization Practices.;

This report updates 1999 recommendations by the Advisory Committee on Immunization Practices (ACIP) on the use of influenza vaccine and antiviral agents (MMWR 1999;48[No. RR-4]: 1-29). These recommendations include five principal changes: a) the age ...

In 2010, the Advisory Committee on Immunization Practices (ACIP) first recommended annual influenza vaccination for all persons aged ?6 months in the United States. Annual influenza vaccination of all persons aged ?6 months continues to be recommende...

This report updates the 2013 recommendations by the Advisory Committee on Immunization Practices (ACIP) regarding use of seasonal influenza vaccines. Updated information for the 2014-15 influenza season includes 1) antigenic composition of U.S. seaso...

This report updates the 2014 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines. Updated information for the 2015-16 season includes 1) antigenic composition of U.S. seasonal in...

Phosphate ester flame retardants are human-made chemicals added to consumer and industrial products for the purpose of reducing flammability. : Phosphate ester flame retardants are composed of a group of chemicals with similar properties but slightly...